GlassScriptPhysician profile
William V Ritzel
NPI 1699763458
$869.38
in general payments reported to CMS, 2019-2025
9 companies · $29.48 in 2025
The $29.48 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $350 · 2020: $31.14 · 2021: $98.09 · 2022: $88.83 · 2023: $46.52 · 2024: $225 · 2025: $29.48.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $241 · Entertainment: $60.15.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $240.98 |
| Entertainment | $60.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $314.60 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $272.40 | 2022-2024 | Infuse |
| Johnson & Johnson Vision Care, INC. | $68.01 | 2019 | |
| Optos, INC. | $60.15 | 2023-2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Coopervision INC. | $39.95 | 2019-2022 | |
| Johnson & Johnson Surgical Vision, INC. | $39.18 | 2021 | |
| Abb Con-Cise Optical Group LLC | $37.80 | 2019-2022 | |
| Aerie Pharmaceuticals, INC. | $20.63 | 2019 | |
| Alcon Vision LLC | $16.66 | 2023 | Total30 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Ritzel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.